The Monoclonal Antibody Infusion Clinic uses Regeneron for the treatment of mild to moderate COVID-19. Regeneron infusion is an investigational drug available under the FDA’s Emergency Use Authorization (EUA).

Monoclonal Antibody Infusion Clinic
at Hamilton Medical Center
706.217.2149